GSK256073

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

Diabetes Mellitus, Type 2DyslipidaemiasDyslipidemias

Phase 1

Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects

CompletedNCT00808093

GlaxoSmithKlineDyslipidaemias

Start: 2008-05-12End: 2008-08-27Updated: 2017-06-05

A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics

CompletedNCT01147861

GlaxoSmithKlineDiabetes Mellitus, Type 2

Start: 2010-07-01End: 2010-09-07Updated: 2017-06-14

Phase 2

Study to Test GSK256073 in Patients With Dyslipidemia

CompletedNCT00903617

GlaxoSmithKlineDyslipidaemias, Dyslipidemias

Start: 2009-06-15End: 2010-02-16Updated: 2019-12-05